Amichay Meirovitz-Rotstein

Dental Branch
Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.

Journal: Frontiers in molecular biosciences

Published: May 11, 2026

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

Journal: Medical sciences (Basel, Switzerland)

Published: April 24, 2026

Metabolic Endotoxemia Amplifies Estrogen Signaling Through Stromal Crosstalk in Obesity-Associated Breast Cancer.

Metabolic Endotoxemia Amplifies Estrogen Signaling Through Stromal Crosstalk in Obesity-Associated Breast Cancer.

Journal: International journal of molecular sciences

Published: March 31, 2026

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

Journal: Medicina (Kaunas, Lithuania)

Published: March 30, 2026

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

Journal: Medical sciences (Basel, Switzerland)

Published: March 09, 2026

Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.

Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.

Journal: Frontiers in molecular biosciences

Published: March 03, 2026

Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy.

Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy.

Journal: Life (Basel, Switzerland)

Published: March 02, 2026

Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients.

Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients.

Journal: International journal of molecular sciences

Published: January 07, 2026

The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology.

The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern Oncology.

Journal: Diagnostics (Basel, Switzerland)

Published: October 20, 2025

Unraveling the Role of Metabolic Endotoxemia in Accelerating Breast Tumor Progression.

Unraveling the Role of Metabolic Endotoxemia in Accelerating Breast Tumor Progression.

Journal: Biomedicines

Published: June 12, 2025

Risk-adapted SBRT ([Formula: see text]) for recurrent lung-only metastases in patients with frailty or ultracentral anatomy.

Risk-adapted SBRT ([Formula: see text]) for recurrent lung-only metastases in patients with frailty or ultracentral anatomy.

Journal: Radiation oncology (London, England)

Published: May 01, 2025

Awake craniotomy vs general anesthesia for brain metastases in eloquent areas: neurological and survival outcomes.

Awake craniotomy vs general anesthesia for brain metastases in eloquent areas: neurological and survival outcomes.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: March 28, 2025

Showing 1-12 of 84

Last Updated: 09/26/2026